Neuroblastoma trials in Finland

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies

  Where

  Helsinki

  Age

  Up to 64 years

  People

  72 worldwide

  Run by

  Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  See details and how to join2023-504880-18-00
• Phase 3Taking people
  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Where

  Helsinki, Kuopio, Oulu, Tampere, Turku

  Age

  Up to 21 years

  People

  800 worldwide

  Run by

  Gustave Roussy, Cancer Campus, Grand Paris

  See details and how to joinNCT04221035 · EU 2024-514917-36-00